ArticleGynecologic oncology2016
Dying well: How equal is end of life care among gynecologic oncology patients?
Article in Gynecologic oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.
- How does ethnicity affect presence of advance care planning in care records for individuals with advanced disease? A mixed-methods systematic review.BMC palliative care · 2023Pooled it
- Trial
- Sociodemographic disparities and hospice referral practice patterns among patients with recurrent cervical cancer.Gynecologic oncology reports · 2026Article
- Trends in hospice referral timing and location among individuals dying of ovarian cancer: persistence of missed opportunities.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2023Article
- Temporal trends and barriers for inpatient palliative care referral in metastatic gynecologic cancer patients receiving specific critical care therapies.Frontiers in oncology · 2023Article
- Physician Influence on Variation in Receipt of Aggressive End-of-Life Care Among Women Dying of Ovarian Cancer.JCO oncology practice · 2022Article
- Trends and racial disparities in aggressive end-of-life care for a national sample of women with ovarian cancer.Cancer · 2021Article
- Health Care Access Measures and Palliative Care Use by Race/Ethnicity among Metastatic Gynecological Cancer Patients in the United States.International journal of environmental research and public health · 2021Article
- Racial and ethnic disparities in palliative care utilization among gynecological cancer patients.Gynecologic oncology · 2021Article
- Intensity of End-of-Life Care in a Cohort of Commercially Insured Women With Metastatic Breast Cancer in the United States.JCO oncology practice · 2021Article
- End-of-Life Concerns and Experiences of Living With Advanced Breast Cancer Among Medically Underserved Women.Journal of pain and symptom management · 2019Article
- How we use hospice: Hospice enrollment patterns and costs in elderly ovarian cancer patients.Gynecologic oncology · 2019Article
- Predictors of Late Palliative Care Referral in Children With Cancer.Journal of pain and symptom management · 2018Article
- Trends in end-of-life care and health care spending in women with uterine cancer.American journal of obstetrics and gynecology · 2017Observational
- Practice Patterns, Attitudes, and Barriers to Palliative Care Consultation by Gynecologic Oncologists.Journal of oncology practice · 2017Article
- End-of-Life Racial and Ethnic Disparities Among Patients With Ovarian Cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
Abstract
objectiveTo identify disparities in utilization of end of life (EoL) resources by gynecologic oncology (GO) patients.
methodsThis retrospective analysis of the medical records of GO patients treated 1/2007-12/2011 and deceased 1/2012-8/2014 evaluated patient demographics, disease characteristics, and utilization of EoL resources. Chi-square, Fisher's exact test, Mann Whitney and Kruskal-Wallis tests were used for statistical analysis.
resultsOf 189 patients analyzed, 113 (60%) were white, 38 (20%) Hispanic, 31 (16%) black, and seven (4%) Asian. Ninety-five (48%) had ovarian cancer, 51 (26%) uterine, 47 (23%) cervical, seven (3%) vulvar/vaginal. In the last 30days of life (DoL), 18 (10%) had multiple hospital admissions, 10 (5%) admitted to the Intensive Care Unit (ICU), 30 (16%) multiple Emergency Room (ER) visits, 45 (24%) received aggressive medical care and eight (4%) received chemotherapy in the final 14 DoL. Furthermore, 54 (29%) had no Supportive Care referral and 29 (15%) no hospice referral. Only 46 (24%) had a Medical Power of Attorney (PoA) or Living Will (LW) on file. Non-white race was associated with increased odds of dying without hospice (OR 3.07; 95%CI [1.27, 2.46], p=0.013). However, non-white patients who enrolled in hospice did so earlier than white patients (42 v. 27days before death, p=0.054). Non-white patients were also significantly less likely to have PoA/LW documentation (24% v. 76%, p=0.009) even if enrolled in hospice (12% v. 31%, p=0.007).
conclusionsSignificant racial disparities in hospice enrollment and PoA/LW documentation were seen in GO patients. This warrants further study to identify barriers to use of EoL resources.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.